Comparing effects of local injection of bupivacaine with and without fentanyl at the site of surgery in open reduction mandibular surgeries on acute pain intensity and opioid requirement: a randomized clinical trial
Comparing effects of local injection of bupivacaine with and without fentanyl at the site of surgery in open reduction mandibular surgeries on acute pain intensity and opioid requirement: a randomized clinical trial.
Design
A clinical trial with a parallel intervention group, double-blind, randomized, phase two on 44 patients. The sampling method is random. Randomization using a table of random numbers is Random allocation software.
Settings and conduct
Among the patients referred to Maxillofacial Surgery Department of Imam Reza Tabriz Hospital, who are candidates for open surgery for isolated mandibular fracture, participate in the study. Patients are randomly assigned to one of the groups. In the control group, after the surgery and after the sutures, 2 cc of bupivacaine 0.5% (5mg/ml) solution and in the intervention group 2cc of bupivacaine 0.5% (5mg/ml) solution along with 25 micrograms of fentanyl in the surgical site. After discharge from recovery, patients' pain will be measured every four hours for 24 hours using a ten-point VAS scale. The patient is aware of the existence of two types of treatment, but he does not know which group he is in. The data importers in the relevant checklist are not aware of the type of intervention.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Patients who are candidates for open mandibular surgery, except for comminuted and condylar fractures, Surgery performed by one person, ASA class one and two patients
Exclusion criteria: The occurrence of any complications that prevent participation in the study, Hypersensitivity to fentanyl, bupivacaine, and other drugs, The presence of infection in the operation site
Intervention groups
Intervention: bupivacaine injection with fentanyl after surgery
Control: bupivacaine injection without fentanyl after surgery
Main outcome variables
The amount of pain
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20220727055567N1
Registration date:2022-08-12, 1401/05/21
Registration timing:registered_while_recruiting
Last update:2022-08-12, 1401/05/21
Update count:0
Registration date
2022-08-12, 1401/05/21
Registrant information
Name
Vahid Baybourdi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 914 245 4919
Email address
baybourdi@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-08-03, 1401/05/12
Expected recruitment end date
2022-08-30, 1401/06/08
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparing effects of local injection of bupivacaine with and without fentanyl at the site of surgery in open reduction mandibular surgeries on acute pain intensity and opioid requirement: a randomized clinical trial
Public title
The effect of fentanyl in reducing pain after jaw surgery
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Candidate patients for open mandibular surgery
Age above 18 years
Duration of surgery less than 4 hours
Candidate patients for general anesthesia
Consent to jaw fixation
Exclusion criteria:
Unwillingness to cooperate in the study
The occurrence of any complications that prevent participation in the study
Hypersensitivity to fentanyl, bupivacaine, and other drugs
The patient's lack of satisfaction with intermaxillary fixation after the operation
Existence of underlying disease and confounding factor such as: hemorrhagic diseases and coagulopathy, kidney and liver diseases, mental and neurological diseases, obstructive lung diseases, hemostatic disorders and dialysis in patients
Addiction to drugs and psychoactive substances and history of drug abuse
The presence of infection in the operation site
History of taking antidepressants and sedatives and any medicine that changes the perception of pain
Age
From 18 years old
Gender
Both
Phase
2
Groups that have been masked
Participant
Investigator
Sample size
Target sample size:
44
Randomization (investigator's opinion)
Randomized
Randomization description
Random sampling will be done among the patients referred to the maxillofacial surgery department of Imam Reza Hospital in Tabriz who is eligible for the study. The randomization method is simple and its unit is the individual. Our tool for randomizing is the random number table. Accordingly, the type of treatment is marked with the code A (bupivacaine with fentanyl) and B (bupivacaine without fentanyl) and will be placed inside the sealed envelopes; Then the envelopes will be placed in a bag and mixed. After that, it will be randomly chosen from the bag and upon viewing the code, the treatment will be given to the patient. None of the patients will be informed about the treatment of another patient.
Blinding (investigator's opinion)
Double blinded
Blinding description
This study is double-blind, so patients do not know which group they will be in. The researcher who must enter data into the checklist will not know which intervention was conducted. Patients are aware of the existence of two types of treatment, but they do not know which group they belong to.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
كميته اخلاق دانشگاه علوم پزشکی تبریز
Street address
Golgasht St., Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Approval date
2022-06-27, 1401/04/06
Ethics committee reference number
IR.TBZMED.REC.1401.307
Health conditions studied
1
Description of health condition studied
Fracture of mandible
ICD-10 code
S02.6
ICD-10 code description
Fracture of mandible
Primary outcomes
1
Description
The amount of pain
Timepoint
Every four hours for 24 hours after surgery
Method of measurement
Visual Analogue Scale
Secondary outcomes
1
Description
The amount of opioid use
Timepoint
Every four hours for 24 hours after surgery
Method of measurement
After surgery, the pain level is measured every four hours for 24 hours. If VAS is higher than 5, Pethidine (Exir Company-Iran) will be injected intramuscularly at the rate of 1 mg/kg. After four hours, if the pain repeats, Pethidine injection at the rate of 1 mg/kg will be repeated. The number of times the patient needs pethidine in twenty-four hours will be recorded.
Intervention groups
1
Description
Intervention group: After the surgery is completed and the sutures are applied, 2 cc of Bupivacaine solution (Exir Company-Iran) 0.5% (5 mg/ml) along with 25 micrograms of fentanyl routinely used in the hospital will be injected into the surgical site through an insulin syringe. After discharge from recovery, patients' pain will be measured by a ten-point VAS scale for 24 hours every four hours. Also, the amount of opioid medication needed based on milligrams of pethidine will also be recorded for patients. If the pain intensity of the patients is higher than 5, pethidine will be injected intramuscularly at the rate of 1 mg/kg.
Category
Treatment - Drugs
2
Description
Control group: After the surgery is completed and the sutures are applied, 2 cc of Bupivacaine solution (Exir Company-Iran) 0.5% (5 mg/ml) will be injected into the surgical site by an insulin syringe. After discharge from recovery, patients' pain will be measured by a ten-point VAS scale for 24 hours every four hours. Also, the amount of opioid medication needed based on milligrams of pethidine will also be recorded for patients. If the pain intensity of the patients is higher than 5, pethidine will be injected intramuscularly at the rate of 1 mg/kg.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Imam Reza Hospital in Tabriz
Full name of responsible person
Saeed Nezafati
Street address
Golgasht St., Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 44 3344 4598
Email
nezaf2000@yahoo.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Mojgan Kachoei
Street address
Golgasht St., Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 44 3344 4598
Email
nezaf2000@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tabriz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Saeed Nezafati
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Golgasht St., Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 44 3344 4598
Email
nezaf2000@yahoo.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Saeed Nezafati
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Golgasht St., Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 44 3344 4598
Email
nezaf2000@yahoo.com
Person responsible for updating data
Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Saeed Nezafati
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Golgasht St., Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 44 3344 4598
Email
nezaf2000@yahoo.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Not applicable
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available